Phase I study of paclitaxel and epirubicin in patients with metastatic breast cancer: A preliminary report on safety

Seminars in Oncology

Volumn 23, Issue 1 SUPPL. 1, 1996, Pages 24-27

  Catimel, G ^a   Spielmann, M ^a   Dieras, V ^a   Kayitalire, L ^a   Pouillart, P ^a   Guastalla, J P ^a   Soler Michel, P ^a   Graffand, N ^a   Garet, F ^a   Dumortier, A ^a   Pellae Cosset, B ^a   Chazard, M ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPIRUBICIN; PACLITAXEL;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DOSE CALCULATION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENCE RISK;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; EPIRUBICIN; FEMALE; FEVER; HEART DISEASES; HUMANS; MIDDLE AGED; NEUTROPENIA; PACLITAXEL;

EID: 0029968348     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)